Developed by the University of Washington and Washington State University

The process for establishing "prior learning" expertise in Medical Literature Evaluation will require the adequate documentation of several skills including the ability to adequately critique articles from the primary literature. Below is the preferred format for submission of submit a write-up of an randomized controlled trial and a pharmacoepidemiology study.


INTRODUCTION

Title: Use the study or article's title, verbatim.

Authors:

Funding. Drug company versus government agency versus foundation, etc. No need to list exact name of funding grant. Speculate if you are not sure (although state that funding source wasn't obvious).

Study Objective. A single sentence description of the study purpose. Use your own words rather than those of the authors whenever possible.

Background. You will need to explain:


METHODS

Design. This should be a short descriptive phrase describing study design.

Setting. Where did the study geographically take place? (e.g., Netherlands, Northeast USA, 37 countries around the world).

Sample population. Describe the entire group of patients available to the investigators from which the sample was drawn. Do not describe the sample.

Inclusion criteria. Paraphrase where possible, particularly if these are extensive.

Exclusion criteria. Omit if information basically covered in inclusion criteria.

Intervention. Include information about:

Major study endpoints. (primary and secondary outcome measures). Endpoints may be event rates, percent change, or relationships between events and risk factors (risk, odds, hazards). You should be able to define each endpoint with 2-5 words. Please only list the major endpoints. Don't detail every single outcome the investigators examined.

Statistical analysis.


RESULTS

Patients.

Endpoints.

*These can be fractions, rates, risk, percent change; if risk, report absolute risk differences as well as relative risk reduction
**p-values and/or confidence intervals

DISCUSSION


EVALUATION

Study strengths.

Study weaknesses.

Usefulness. Here you present your overall opinion of the study. State how the study could fit into your practice or describe how you think the information could be used (or is useless).



External PharmD Home Page | Top of the Page |


Stanley S. Weber, Pharm.D, FASHP, BCPP
Director, Joint Doctor of Pharmacy Degree Program
University of Washington and Washington State University
Copyright © 2006
Comments: expharmd@u.washington.edu
Revised: January 6, 2006